XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.22.2.2

MARKETABLE SECURITIES | 9 Months Ended
--- | ---
Sep. 30, 2022
Marketable Securities Abstract |
MARKETABLE SECURITIES | 5. MARKETABLE SECURITIES: Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at September 30, 2022, were as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amortized | ​ | Gross Unrealized | ​ | Estimated Fair
(In thousands) |  | Cost |  | Gains |  | Losses |  | Market Value
Investments due in 3 months or less: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Corporate securities | ​ | $ | 8,412 | ​ | $ | — | ​ | $ | (36) | ​ | $ | 8,376
Total | ​ |  | 8,412 | ​ |  | — | ​ |  | (36) | ​ |  | 8,376
Investments due in 4-12 months: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ |  | 159,313 | ​ |  | — | ​ |  | (4,369) | ​ |  | 154,944
Total | ​ |  | 159,313 | ​ |  | — | ​ |  | (4,369) | ​ |  | 154,944
Investments due in 12 months or greater: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ |  | 69,266 | ​ |  | — | ​ |  | (2,832) | ​ |  | 66,434
Total | ​ | ​ | 69,266 | ​ |  | — | ​ | ​ | (2,832) | ​ |  | 66,434
Total marketable securities | ​ | $ | 236,991 | ​ | $ | — | ​ | $ | (7,237) | ​ | $ | 229,754
​ Accrued interest receivable was $1.3 million at September 30, 2022 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet. Amortized cost and estimated fair market value of marketable securities classified as available-for-sale (excluding cash equivalents) at December 31, 2021, were as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amortized | ​ | Gross Unrealized | ​ | Estimated Fair
(In thousands) |  | Cost |  | Gains |  | Losses |  | Market Value
Investments due in 3 months or less: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Commercial paper | ​ | $ | 89,965 | ​ | $ | — | ​ | $ | — | ​ | $ | 89,965
Corporate securities | ​ | ​ | 7,285 | ​ | ​ | — | ​ | ​ | (3) | ​ | ​ | 7,282
Total | ​ |  | 97,250 | ​ |  | — | ​ |  | (3) | ​ |  | 97,247
Investments due in 4-12 months: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ |  | 25,054 | ​ |  | — | ​ |  | (42) | ​ |  | 25,012
Total | ​ |  | 25,054 | ​ |  | — | ​ |  | (42) | ​ |  | 25,012
Investments due in 12 months or greater: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Corporate securities | ​ | ​ | 251,096 | ​ |  | 21 | ​ |  | (1,141) | ​ |  | 249,976
Total | ​ |  | 251,096 | ​ |  | 21 | ​ |  | (1,141) | ​ |  | 249,976
Total marketable securities | ​ | $ | 373,400 | ​ | $ | 21 | ​ | $ | (1,186) | ​ | $ | 372,235
​ Accrued interest receivable was $1.5 million at December 31, 2021 and was recorded within prepaid expenses and other current assets on the condensed consolidated balance sheet. The following table summarizes marketable securities classified as available-for-sale (excluding cash equivalents) in a continuous unrealized loss position for which an allowance for credit losses was not recorded at September 30, 2022:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Less Than 12 Months | ​ | 12 Months or Longer | ​ | Total
​ |  | Estimated |  | Gross |  | Estimated |  | Gross |  | Estimated |  | Gross
​ | ​ | Fair Market | ​ | Unrealized | ​ | Fair Market | ​ | Unrealized | ​ | Fair Market | ​ | Unrealized
(In thousands) | ​ | Value | ​ | Losses | ​ | Value | ​ | Losses | ​ | Value | ​ | Losses
Corporate securities | ​ | $ | 178,374 | ​ | $ | (5,520) | ​ | $ | 51,379 | ​ | $ | (1,717) | ​ | $ | 229,753 | ​ | $ | (7,237)
Total marketable securities | ​ | $ | 178,374 | ​ | $ | (5,520) | ​ | $ | 51,379 | ​ | $ | (1,717) | ​ | $ | 229,753 | ​ | $ | (7,237)
​ In the three and nine months ended September 30, 2022 and 2021, no unrealized losses on marketable securities were recognized in income. The Company does not intend to sell and it is unlikely that it will be required to sell the securities prior to their anticipated recovery. The issuers are high quality (investment grade) and the decline in fair value is largely due to changes in interest rates. Additionally, the issuers continue to make timely interest payments on the marketable securities with the fair value expected to recover as they reach maturity.

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2209399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2176304 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph (b) + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration